degeneration

(redirected from Age-related macular degeneration)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
Related to Age-related macular degeneration: glaucoma, diabetic retinopathy
References in periodicals archive ?
The report provides an analysis of age-related macular degeneration partnering deals.
Lim, Age-Related Macular Degeneration, Informa Healthcare, New York, NY, USA, 2008.
Chew et al., "Complement factor H polymorphism in age-related macular degeneration," Science, vol.
Hollyfield, "Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture," Investigative Ophthalmology and Visual Science, vol.
(16.) Seddon JM, Ajani UA, Sperduto RD, et al: Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272:1413-1420, 1994.
The researchers tested the association of exercising at least three times a week, daily walking, and daily stair-climbing with the onset of early age-related macular degeneration, geographic atrophy, and exudative AMD in the study population.
In an investigation called "A Dietary Antioxidant Index and Risk for Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study" conducted by the National Eye Institute, researchers evaluated the antioxidant intake of more than 1,700 individuals who were between 60 and 80 years of age.
A new market study, titled "Age-Related Macular Degeneration Market Research Report - Global Forecast till 2023" has been featured on Market Research Future.
Drug development company Belite Bio reported on Wednesday the receipt of US Food and Drug Administration (FDA) approval for its Investigational New Drug application (IND) for LBS-008 for the treatment of atrophic Age-related Macular Degeneration (dry AMD) and Stargardt disease, an inherited juvenile form of macular degeneration.
(NYSE American: BTX) announced that updated results from a Phase 1/2a study of its retinal pigment epithelium (RPE) cell transplant therapy in development for the treatment of dry age-related macular degeneration (Dry-AMD), will be presented at the 2019 Association for Research in Vision and Ophthalmology annual meeting (ARVO 2019) on May 2 in Vancouver, BC, Canada.
BioTime announced that updated results from a Phase I/IIa study of its lead product candidate, OpRegen, a retinal pigment epithelium cell transplant therapy currently in development for the treatment of dry age-related macular degeneration, will be presented at the 2019 Association for Research in Vision and Ophthalmology Annual Meeting, to be held April 28 through May 2, 2019 at the Vancouver Convention Centre in Vancouver, BC, Canada.
[USA], Oct 22 (ANI): According to a new study eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD), an eye disease that causes vision loss.